Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis

Hepatology

Volumn 10, Issue 4, 1989, Pages 414-419

  Batta, Ashok K ^a,b,c   Salen, Gerald ^a,b,c   Arora, Renu ^a,b,c   Shefer, Sarah ^a,b,c   Tint, G Stephen ^a,b,c   Abroon, John ^a,b,c   Eskreis, David ^a,b,c   Katz, Seymour ^a,b,c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; URSODEOXYCHOLIC ACID;

DIET RESTRICTION; FEEDING; HUMAN; HUMAN CELL; METABOLISM; ORAL DRUG ADMINISTRATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILE ACIDS AND SALTS; DEOXYCHOLIC ACID; FEMALE; HUMAN; LIVER CIRRHOSIS, BILIARY; MIDDLE AGE; PRURITUS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; URSODEOXYCHOLIC ACID;

EID: 0024467084     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840100404     Document Type: Article

References (37)

1. Bile acid metabolism in health and disease
2. Cholestatic liver disease: mechanisms, diagnosis and therapy
3. Evidence for renal control of urinary excretion of bile acids and bile acid sulfates in the cholestatic syndrome
4. Disturbances of bile acid metabolism in parenchymal liver cell disease
5. Bile acid metabolism in patients with cirrhosis. II. Cholic and chenodeoxycholic acid metabolism
6. Bile acid metabolism in cirrhosis. IV. Characterization of the abnormality in deoxycholic acid metabolism
7. Fasting serum bile acid levels in cirrhosis. A semi quantitative index of hepatic function
8. Bile acid profiles in urine of patients with liver diseases
9. Bile acid metabolism in cirrhosis. VI. Sites of blockage in the bile acid pathways to primary bile acids
10. Bile acid metabolism in cirrhosis. VII. Evidence for defective feedback control of bile acid synthesis
11. The serum trihydroxy‐dihydroxy bile acid ratio in liver and biliary tract disease
12. Serum bile acids in the diagnosis of hepatobiliary disease
13. Biliary deoxycholate in patients with alcoholic cirrhosis
14. Bile acid metabolism in cirrhotic liver tissue‐altered synthesis and impaired hepatic secretion
15. Serum and urinary bile acids in patients with primary biliary cirrhosis
16. Mechanism of cholestasis. 4. Structural and biochemical changes in the liver and serum in rats after bile duct ligation
17. Bile acids, liver injury and liver disease
18. Inhibition of bile formation by high doses of taurocholate in the perfused rat liver
19. Tauroursodeoxycholate prevents biliary excretion of proteins induced by taurocholate and taurochenodeoxycholate in the rat (Abstract)
20. Glycoursodeoxycholate is as effective as tauroursodeoxycholate in preventing the taurocholate induced cholastasis in the rat (Abstract)
21. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis
22. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis: monitoring by high performance liquid chromatography
23. Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid
24. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial
25. A prospective control trial of azathioprine in primary biliary cirrhosis
26. Controlled trial of prednisolone for primary biliary cirrhosis: good for the liver, bad for the bones (Abstract)
27. A prospective clinical trial of d‐penicillamine in the treatment of primary biliary cirrhosis
28. Double‐blind controlled trial of D‐penicillamine in patients with primary biliary cirrhosis
29. Randomized trial of chlorambucil for primary biliary cirrhosis
30. Phenobarbital treatment in primary biliary cirrhosis
31. Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis
32. Evaluation of colchicine therapy in primary biliary cirrhosis
33. Medical treatment of cholesterol gallstones by bile desaturating agents
34. Serum bile acids in liver disease
35. Serum bile acids in primary biliary cirrhosis
36. Bile acids in the skin of patients with pruritic hepatobiliary disease
37. Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and to pruritus